Maastricht psychopharmacologists Mason and Haijen-Bongers call for research on menstrual cycle effects in psychedelic trials
Psychopharmacologists Natasha Mason and Eline Haijen-Bongers argue that clinical trials of psychedelics for depression and PTSD rarely account for female sex hormones, in a review in Nature Molecular Psychiatry. They cite a preprint pooling their psychedelic trial data in which women given the same dose responded more strongly and reported greater anxious ego dissolution. The review notes 5-HT2A receptor density rises when estrogen is high.